MedTrace Logo

Prospective Cohort Study on the Determinants of Venous THromboembolic Recurrence

NCT04297085 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3400

Last updated 2025-09-12

No results posted yet for this study

Summary

The main objective of the BREIZH-Cohorte study is to determine the incidence of recurrent short, medium and long-term thromboembolic venous disease as well as risk factors for recurrence in two specific populations: patients under 50 years of age, men and women (5 year recurrence), as well as cancer patients (all ages) (1 year recurrence).

Conditions

  • Thromboembolic Venous Disease

Interventions

BIOLOGICAL

Biologic sample

Biological samples will be taken from the subjects included

Sponsors & Collaborators

  • University Hospital, Brest

    lead OTHER

Principal Investigators

  • Francis COUTURAUD, MD, PHD · EA3878 (GETBO), Brest University Hospital in France

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-28
Primary Completion
2050-04-30
Completion
2050-04-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04297085 on ClinicalTrials.gov